Search Results 231-240 of 13263 for Assay

  1. Colon Neuroendocrine Tumor Clinical Trials - Mayo Clinic Research

    The purpose of this study is to monitor and validate the performance and stability of the BRAHMS Chromogranin A (CgA) II KRYPTOR Assay in patients with ...

  2. Publications - Min Shi, M.D., Ph.D. - Mayo Clinic

    Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia. Cancers ...

  3. Overview - Antibody Hybridoma Core - Mayo Clinic Research

    Monoclonal antibodies can be used for research and development of clinical diagnostic assays and therapeutics. All Antibody Hybridoma Core services are ...

  4. Epigenetic Analysis of Human Cystic Disease - Genetics Epigenetics and Metabolomics Core - Mayo Clinic Research

    The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers epigenetic services, including DNA methylation assay and gene expression analysis.

  5. NanoString GeoMx WTA + Immuno-Oncology Proteome Atlas (IPA) - Spatial Multiomics Core - Mayo Clinic Research Core Facilities

    Mayo Clinic's Spatial Multiomics Core uses the GeoMx Whole Transcriptome Atlas plus Immuno-Oncology Proteome Atlas proteogenomic assay to profile human or ...

  6. Andrew McKeon, M.B., B.Ch., M.D. - Mayo Clinic Faculty Profiles

    ... assays, phage immunoprecipitation sequencing, and mass spectrometry techniques for verification. Determining validity of novel biomarkers. Newly ...

  7. A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    ... assay. * Archival or fresh tumor material must be submitted for assessment of c-Met levels during the Pre-Screening period. Tumor material from the primary ...

  8. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

    Subjects who are HCV antibody positive will be screened for HCV RNA by any RT-PCR or bDNA assay. If HCV antibody is positive, eligibility will be determined ...

  9. David E. Midthun, M.D. - Mayo Clinic Faculty Profiles

    Midthun is the site principal investigator for the Cancer Screening Assay Using DELFI (CASCADE-LUNG) study and the Screening for High Frequency Malignant ...

  10. A Study of the Quantiferon CMV Blood Test to Predict the Risk of CMV Returning After Treatment of the Disease in Solid Organ Transplant Recipients - Mayo Clinic

    ... assay are at lower risk of CMV recurrence in the future. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...